The Biggest Healthcare Deals of 2020
Believe it or not, 2020 is over in just a few short weeks. Although most of our attention has been absorbed by the pandemic, the presidential election and an endless amount of Zoom calls at work, the healthcare M&A market managed to pull off some eye-catching surprises. The raw numbers and data might pale in comparison to that of 2019, but the activity is worth digging through. Early in December, there have been 1,374 deals announced, according to search results in our Healthcare Deal Database, a roughly 25% drop compared with the 1,841 deals on the books in 2019. Based on our monthly averages for the year, we might see somewhere between 100 and 120 more deals added by the end of... Read More »
Health Care M&A Deals, November 27, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is the purchase and merger of UpHealth and Cloudbreak Health by GigCapital2 Inc., a special purpose acquisition corporation, for $1.35 billion. UpHealth Holdings, Inc. is one of the largest national and international digital healthcare providers, and Cloudbreak Health, LLC is a leading telemedicine and video medical interpretation solutions... Read More »
Health Care M&A Deals, November 20, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is CBPO Holdings Limited’s acquisition of China Biologic Products Holdings, Inc. (NASDAQ: CBPO) for $4.76 billion. Based in Beijing, China Biologic Products Holdings is a leading, fully integrated plasma-based biopharmaceutical company. The company’s products are used as critical therapies during medical emergencies and for the prevention... Read More »
Health Care M&A Deals, November 13, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Cano Health, LLC’s reverse merger with Jaws Acquisition Corp., a special purpose acquisition company. The deal is valued at $4.4 billion. Cano Health operates primary care centers and supports affiliated medical practices in Florida, Texas, Nevada, and Puerto Rico that specialize in value-based care for seniors. As part of its care... Read More »
Health Care M&A Deals, November 6, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Merck & Co., Inc.’s acquisition of VelosBio for $2.75 billion in cash. VelosBio is a privately held clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies. VelosBio’s lead investigational candidate, VLS-101, is currently being evaluated in a Phase 1 and a Phase 2 clinical trial for the treatment... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
